Quinolone resistance mechanisms in Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4,5,12:i:-, isolated from humans in Switzerland, and identification of a novel qnrD variant, qnrD2, in S. Hadar

Antimicrob Agents Chemother. 2014 Jun;58(6):3560-3. doi: 10.1128/AAC.02404-14. Epub 2014 Apr 14.

Abstract

Human isolates of Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and the monophasic variant of S. Typhimurium, Salmonella enterica subsp. enterica serovar 4,5,12:i:- were examined for mutations within the quinolone resistance target genes gyrA, gyrB, parC, and parE and for plasmid-mediated resistance genes. Differences were observed among the serovars. A novel variant of qnrD, qnrD2, was detected in an S. Hadar isolate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Base Sequence
  • DNA Gyrase / genetics*
  • Drug Resistance, Bacterial / genetics*
  • Humans
  • Microbial Sensitivity Tests
  • Nalidixic Acid / pharmacology
  • Plasmids / genetics
  • Quinolones / pharmacology*
  • Salmonella enterica / drug effects
  • Salmonella enterica / genetics*
  • Sequence Analysis, DNA
  • Serogroup
  • Switzerland

Substances

  • Anti-Bacterial Agents
  • Quinolones
  • Nalidixic Acid
  • DNA Gyrase

Associated data

  • GENBANK/KF055448
  • GENBANK/KJ158441